7101 - 7125 of 9033 Results
Title
Year
- A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)2018RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
- Special focus section: Gene therapy for Parkinson's disease2007RESTRICTEDTitle: Special focus section: Gene therapy for Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 209Issue #: 1Start Page: 28End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2007.09.006Citation Count: 6
-
OPENTitle: The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary resultsJournal Name: Journal of Translational MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 348End Page: 348Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12967-015-0704-9Best OA location URL: https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-015-0704-9Citation Count: 105
- Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders2020OPENTitle: Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disordersJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000924Best OA location URL: https://nn.neurology.org/content/nnn/8/1/e924.full.pdfCitation Count: 99
-
OPENTitle: Posterior Cortical Atrophy phenotype in a GBA N370S mutation carrier: a case reportJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page: 17End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-02023-5Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-020-02023-5Citation Count: 6
-
OPENTitle: Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical PracticeJournal Name: Parkinson's DiseasePublisher: WileyVol: 2021Issue #:Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/2603641Best OA location URL: https://downloads.hindawi.com/journals/pd/2021/2603641.pdfCitation Count: 12
-
OPENTitle: Pallidal stimulation as treatment for camptocormia in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 8End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00151-wBest OA location URL: https://www.nature.com/articles/s41531-020-00151-w.pdfCitation Count: 21
-
OPENTitle: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of LevodopaJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/9716317Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/9716317.pdfCitation Count: 19
-
OPENTitle: Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 2Start Page: 335End Page: 344Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.201Best OA location URL: https://escholarship.org/uc/item/7k74z129Citation Count: 120
- Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease2019RESTRICTEDTitle: Risks and benefits of unapproved disease-modifying treatments for neurodegenerative diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 1Start Page: e1End Page: e14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008699Citation Count: 35
-
OPENTitle: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 2479End Page: 2479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-59414-4Best OA location URL: https://www.nature.com/articles/s41598-020-59414-4.pdfCitation Count: 100
-
OPENTitle: Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLsJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 2Start Page: e1008549End Page: e1008549Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1008549Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1008549&type=printableCitation Count: 29
- Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study2019OPENTitle: Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort studyJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 3Start Page: 314End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2019-321794Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/3/314.full.pdfCitation Count: 79
-
OPENTitle: Association of specific biotypes in patients with Parkinson disease and disease progressionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 11Start Page: e1445End Page: e1460Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010498Best OA location URL: https://n.neurology.org/content/neurology/95/11/e1445.full.pdfCitation Count: 38
-
OPENTitle: Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-upJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 19014End Page: 19014Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-75800-4Best OA location URL: https://www.nature.com/articles/s41598-020-75800-4.pdfCitation Count: 26
- Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain2020OPENTitle: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 6Start Page: 696End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-020-0635-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7269838Citation Count: 167
- Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report2020OPENTitle: Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case reportJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page: 227End Page: 227Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01757-6Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-020-01757-6Citation Count: 9
- Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity2020OPENTitle: Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensityJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 2820End Page: 2820Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-020-16564-3Best OA location URL: https://www.nature.com/articles/s41467-020-16564-3.pdfCitation Count: 162
- Capgras Delusion in Posterior Cortical Atrophy–A Quantitative Multimodal Imaging Single Case Study2020OPENTitle: Capgras Delusion in Posterior Cortical Atrophy–A Quantitative Multimodal Imaging Single Case StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: 133End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.00133Best OA location URL: https://doi.org/10.3389/fnagi.2020.00133Citation Count: 6
-
OPENTitle: Association Between Cerebrospinal Fluid Biomarkers and Age-related Brain Changes in Patients with Normal Pressure HydrocephalusJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 9106End Page: 9106Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-66154-yBest OA location URL: https://www.nature.com/articles/s41598-020-66154-y.pdfCitation Count: 20
-
OPENTitle: Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page: 15End Page: 20Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-019-0556-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7257994Citation Count: 181
-
OPENTitle: Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S PatientsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 526End Page: 526Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00526Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00526/pdfCitation Count: 34
-
OPENTitle: The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 31Issue #: 8Start Page: 2556End Page: 2566Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41591-025-03834-0Best OA location URL: https://www.nature.com/articles/s41591-025-03834-0.pdfCitation Count: 79
-
OPENTitle: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemicJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049755Best OA location URL: https://doi.org/10.1242/dmm.049755Citation Count: 0
-
OPENTitle: A blood-based marker of mitochondrial DNA damage in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 15Issue #: 711Start Page: eabo1557End Page: eabo1557Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11135133Citation Count: 80